Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease.

Zhang L, Huang L, Chen L, Hao D, Chen J.

Toxicol Lett. 2013 Oct 24;222(2):155-63. doi: 10.1016/j.toxlet.2013.07.020.

Outcomes of screening Parkinson's patients for QTc prolongation.

Cunnington AL, Hood K, White L.

Parkinsonism Relat Disord. 2013 Nov;19(11):1000-3. doi: 10.1016/j.parkreldis.2013.07.001. Review.

Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson's disease.

Quik M, Mallela A, Ly J, Zhang D.

Mov Disord. 2013 Sep;28(10):1398-406. doi: 10.1002/mds.25594.

Videofluorographic assessment of deglutitive behaviors in a rat model of aging and Parkinson disease.

Russell JA, Ciucci MR, Hammer MJ, Connor NP.

Dysphagia. 2013 Mar;28(1):95-104. doi: 10.1007/s00455-012-9417-x.

Using the Montreal Cognitive Assessment Scale to screen for dementia in Chinese patients with Parkinson's Disease.

Chen L, Yu C, Fu X, Liu W, Hua P, Zhang N, Kuo S.

Shanghai Arch Psychiatry. 2013 Oct;25(5):296-305. doi: 10.3969/j.issn.1002-0829.2013.05.005.

Effect of externally cued training on dynamic stability control during the sit-to-stand task in people with Parkinson disease.

Bhatt T, Yang F, Mak MK, Hui-Chan CW, Pai YC.

Phys Ther. 2013 Apr;93(4):492-503. doi: 10.2522/ptj.20100423.

Driving and off-road impairments underlying failure on road testing in Parkinson's disease.

Devos H, Vandenberghe W, Tant M, Akinwuntan AE, De Weerdt W, Nieuwboer A, Uc EY.

Mov Disord. 2013 Dec;28(14):1949-56. doi: 10.1002/mds.25701.

Pathologic thoracic spine fracture in presence of Parkinson's disease and diffuse ankylosis: successful management of a challenging condition.

Aoki Y, Nakajima A, Sakakibara R, Ohtori S, Takahashi K, Nakagawa K.

BMC Musculoskelet Disord. 2013 Feb 11;14:61. doi: 10.1186/1471-2474-14-61.

The safety and tolerability of rotigotine transdermal system over a 6-year period in patients with early-stage Parkinson's disease.

Giladi N, Boroojerdi B, Surmann E.

J Neural Transm (Vienna). 2013 Sep;120(9):1321-9. doi: 10.1007/s00702-013-1001-5.

Tnfaip8l1/Oxi-β binds to FBXW5, increasing autophagy through activation of TSC2 in a Parkinson's disease model.

Ha JY, Kim JS, Kang YH, Bok E, Kim YS, Son JH.

J Neurochem. 2013 Dec 26. doi: 10.1111/j.1471-4159.2013.12643.x. [Epub ahead of print]

Falls in Parkinson disease: analysis of a large cross-sectional cohort.

Parashos SA, Wielinski CL, Giladi N, Gurevich T; National Parkinson Foundation Quality Improvement Initiative Investigators..

J Parkinsons Dis. 2013;3(4):515-22. doi: 10.3233/JPD-130249.

What's to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?

Dunning CJ, George S, Brundin P.

Prion. 2013 Jan-Feb;7(1):92-7. doi: 10.4161/pri.23806. Review.

Instruments for holistic assessment of Parkinson's disease.

Martinez-Martin P.

J Neural Transm (Vienna). 2013 Apr;120(4):559-64. doi: 10.1007/s00702-013-1005-1. Review.

[DBS therapy for Parkinson's disease - our approach].

Sato S, Takiyama Y, Ogino Y, Watanabe K, Terao T, Matsumoto C, Chiken S, Nambu A, Nishiyama K, Kumabe T, Fujii K.

Rinsho Shinkeigaku. 2013;53(11):1053-5. Review. Japanese.

Dopamine: PET Imaging and Parkinson Disease.

Peng S, Doudet DJ, Dhawan V, Ma Y.

PET Clin. 2013 Oct;8(4):469-85. doi: 10.1016/j.cpet.2013.08.003.